EX-FILING FEES 4 ex_452194.htm EXHIBIT FILING FEES ex_452194.htm

 


Exhibit 107

 

Calculation of Filing Fee Table

S-3

(Form Type)

Compass Therapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities and Carry Forward Securities

 

   

Security

Type

   

Security

Class

Title

   

Fee

Calculation

or

Carry

Forward

Rule

   

Amount

Registered (1)

   

Proposed

Maximum

Offering

Price

Per Unit (2)

   

Maximum

Aggregate

Offering

Price

   

Fee

Rate

   

Amount

of

Registration

Fee

 

Newly Registered Securities

 

Fees

to Be

Paid

 

Equity

   

Common stock, par value $0.0001 per share

   

457(c)

      25,000,000     $ 4.06     $ 101,500,000     $ 0.00011020     $ 11,185.30  

Carry Forward Securities

 

Carry

Forward

Securities

    --       --       --       --       --       --       --       --  
 

Total Offering Amounts

          $ 101,500,000             $ 11,185.30  
 

Total Fees Previously Paid

                            --  
 

Total Fee Offsets

                            --  
 

Net Fee Due

                          $ 11,185.30  

(1)

Represents shares offered by the selling stockholders identified in the registration statement to which this exhibit relates. Includes an indeterminable number of additional shares of common stock that, pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), that may be issued to prevent dilution from stock splits, stock dividends or similar transactions that could affect the shares to be offered by the selling stockholders.

(2)

Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(c) under the Securities Act, based on the average of the high and low prices per share of the registrant’s common stock on the Nasdaq Capital Market on November 30, 2022.